MovDisordV3, Main, Exploration, bibRecord, 005638

High‐dose pergolide monotherapy in the treatment of severe levodopa‐induced dyskinesias

Identifieur interne : 005638 ( Main/Exploration ); précédent : 005637; suivant : 005639

High‐dose pergolide monotherapy in the treatment of severe levodopa‐induced dyskinesias

Auteurs : Alicia Facca [États-Unis] ; Juan Sanchez-Ramos [États-Unis]

Source :

Movement Disorders [ 0885-3185 ] ; 1996-05.

RBID : ISTEX:C5D581C9CFD60850CD6F1F2BFC777534FC58EBDC

English descriptors

KwdEn :
- Aged, Antiparkinson Agents (administration & dosage), Antiparkinson Agents (adverse effects), Carbidopa (administration & dosage), Carbidopa (adverse effects), Dopamine Agonists (administration & dosage), Dopamine Agonists (adverse effects), Dose-Response Relationship, Drug, Drug Therapy, Combination, Dyskinesia, Drug-Induced (diagnosis), Dyskinesia, Drug-Induced (drug therapy), Female, Humans, Levodopa (administration & dosage), Levodopa (adverse effects), Male, Middle Aged, Neurologic Examination (drug effects), Parkinson Disease (drug therapy), Pergolide (administration & dosage), Pergolide (adverse effects).
MESH :
- chemical , administration & dosage : Antiparkinson Agents, Carbidopa, Dopamine Agonists, Levodopa, Pergolide.
- chemical , adverse effects : Antiparkinson Agents, Carbidopa, Dopamine Agonists, Levodopa, Pergolide.
- diagnosis : Dyskinesia, Drug-Induced.
- drug effects : Neurologic Examination.
- drug therapy : Dyskinesia, Drug-Induced, Parkinson Disease.
- Aged, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Humans, Male, Middle Aged.

Url:

https://api.istex.fr/document/C5D581C9CFD60850CD6F1F2BFC777534FC58EBDC/fulltext/pdf

DOI: 10.1002/mds.870110319

Affiliations:

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">High‐dose pergolide monotherapy in the treatment of severe levodopa‐induced dyskinesias</title>
<author><name sortKey="Facca, Alicia" sort="Facca, Alicia" uniqKey="Facca A" first="Alicia" last="Facca">Alicia Facca</name>
</author>
<author><name sortKey="Sanchez Amos, Juan" sort="Sanchez Amos, Juan" uniqKey="Sanchez Amos J" first="Juan" last="Sanchez-Ramos">Juan Sanchez-Ramos</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C5D581C9CFD60850CD6F1F2BFC777534FC58EBDC</idno>
<date when="1996" year="1996">1996</date>
<idno type="doi">10.1002/mds.870110319</idno>
<idno type="url">https://api.istex.fr/document/C5D581C9CFD60850CD6F1F2BFC777534FC58EBDC/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003A79</idno>
<idno type="wicri:Area/Istex/Curation">003A79</idno>
<idno type="wicri:Area/Istex/Checkpoint">003B40</idno>
<idno type="wicri:doubleKey">0885-3185:1996:Facca A:high:dose:pergolide</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:8723153</idno>
<idno type="wicri:Area/PubMed/Corpus">004830</idno>
<idno type="wicri:Area/PubMed/Curation">004830</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004815</idno>
<idno type="wicri:Area/Ncbi/Merge">004B05</idno>
<idno type="wicri:Area/Ncbi/Curation">004B05</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004B05</idno>
<idno type="wicri:doubleKey">0885-3185:1996:Facca A:high:dose:pergolide</idno>
<idno type="wicri:Area/Main/Merge">008744</idno>
<idno type="wicri:Area/Main/Curation">005638</idno>
<idno type="wicri:Area/Main/Exploration">005638</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">High‐dose pergolide monotherapy in the treatment of severe levodopa‐induced dyskinesias</title>
<author><name sortKey="Facca, Alicia" sort="Facca, Alicia" uniqKey="Facca A" first="Alicia" last="Facca">Alicia Facca</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Movement Disorders Center Department of Neurology University of Miami School of Medicine, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sanchez Amos, Juan" sort="Sanchez Amos, Juan" uniqKey="Sanchez Amos J" first="Juan" last="Sanchez-Ramos">Juan Sanchez-Ramos</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Geriatric Research and Educational Clinical Center Miami Veterans' Affairs Medical Center Miami, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1996-05">1996-05</date>
<biblScope unit="vol">11</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="327">327</biblScope>
<biblScope unit="page" to="329">329</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">C5D581C9CFD60850CD6F1F2BFC777534FC58EBDC</idno>
<idno type="DOI">10.1002/mds.870110319</idno>
<idno type="ArticleID">MDS870110319</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Antiparkinson Agents (administration & dosage)</term>
<term>Antiparkinson Agents (adverse effects)</term>
<term>Carbidopa (administration & dosage)</term>
<term>Carbidopa (adverse effects)</term>
<term>Dopamine Agonists (administration & dosage)</term>
<term>Dopamine Agonists (adverse effects)</term>
<term>Dose-Response Relationship, Drug</term>
<term>Drug Therapy, Combination</term>
<term>Dyskinesia, Drug-Induced (diagnosis)</term>
<term>Dyskinesia, Drug-Induced (drug therapy)</term>
<term>Female</term>
<term>Humans</term>
<term>Levodopa (administration & dosage)</term>
<term>Levodopa (adverse effects)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neurologic Examination (drug effects)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Pergolide (administration & dosage)</term>
<term>Pergolide (adverse effects)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Carbidopa</term>
<term>Dopamine Agonists</term>
<term>Levodopa</term>
<term>Pergolide</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Carbidopa</term>
<term>Dopamine Agonists</term>
<term>Levodopa</term>
<term>Pergolide</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Neurologic Examination</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Dose-Response Relationship, Drug</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Floride</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Floride"><name sortKey="Facca, Alicia" sort="Facca, Alicia" uniqKey="Facca A" first="Alicia" last="Facca">Alicia Facca</name>
</region>
<name sortKey="Sanchez Amos, Juan" sort="Sanchez Amos, Juan" uniqKey="Sanchez Amos J" first="Juan" last="Sanchez-Ramos">Juan Sanchez-Ramos</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005638 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005638 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:C5D581C9CFD60850CD6F1F2BFC777534FC58EBDC
   |texte=   High‐dose pergolide monotherapy in the treatment of severe levodopa‐induced dyskinesias
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

High‐dose pergolide monotherapy in the treatment of severe levodopa‐induced dyskinesias

High‐dose pergolide monotherapy in the treatment of severe levodopa‐induced dyskinesias

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.